Paper Details
- Home
- Paper Details
Dynamic urine proteome changes in a rat model of simvastatin-induced skeletal muscle injury.
Author: GaoYouhe, HengZiqi, HuanYuhang, JiaLulu, WeiJing, YuYuncui, ZhaoChenyang
Original Abstract of the Article :
Statin-associated muscle symptoms (SAMS) are the main side effects of statins. Currently, there are no effective biomarkers for accurate clinical diagnosis. Urine is not subject to homeostatic control and therefore accumulates early changes, making it an ideal biomarker source. We therefore examined...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元:
https://doi.org/10.1016/j.jprot.2021.104477
データ提供:米国国立医学図書館(NLM)
Unraveling the Mysteries of Statin-Associated Muscle Symptoms: A Look at the Urinary Proteome
Statin-associated muscle symptoms (SAMS) are a common side effect of statins, like a desert traveler experiencing fatigue and muscle cramps after a long trek. This study investigates the changes in the urinary proteome of rats treated with simvastatin, hoping to uncover potential biomarkers for early detection and diagnosis of SAMS.Mapping the Desert of Muscle Injury: Exploring the Urinary Proteome
The researchers examined the urine proteome of rats with SAMS over time, analyzing changes in protein levels. This is like using a map to trace the path of a sandstorm, observing the changes in the landscape as the storm progresses. The results revealed specific changes in proteins associated with muscle damage, metabolism, and apoptosis, potentially providing valuable clues for early detection and intervention.Finding the Oasis of Hope: Potential Biomarkers for Early Diagnosis
The study identifies several proteins in urine that are linked to SAMS, potentially serving as biomarkers for early diagnosis. This is like finding a hidden oasis in the desert, providing a vital source of water and resources. These findings offer a promising avenue for developing non-invasive methods for monitoring drug side effects and improving patient care.Dr. Camel's Conclusion
This study sheds light on the potential of urinary proteomics to unravel the mysteries of statin-associated muscle symptoms. The findings offer promising leads for developing novel biomarkers for early detection and diagnosis, paving the way for more effective management of drug side effects. It is like finding a new path through the desert of medical research, leading us closer to a better understanding of complex conditions and improving patient outcomes.Date :
- Date Completed 2022-02-28
- Date Revised 2022-05-31
Further Info :
Related Literature
Article Analysis
SNS
PICO Info
in preparation
Languages
English
Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.